| # | Drug | Count |
|---|---|---|
| 0 | BISOPROLOL FUMARATE | 28 |
| 1 | VALSARTAN | 28 |
| 2 | VALSARTAN ORAL | 28 |
| 3 | ASPIRIN | 23 |
| 4 | ASPIRIN 325 MG | 23 |
| 5 | ASPIRIN 81 MG | 23 |
| 6 | METHOTREXATE SODIUM | 20 |
| 7 | TACROLIMUS | 17 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 9 | TACROLIMUS OINTMENT 0.1% | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VARDENAFIL | 1 | 0.0017 |
| 1 | PROPAFENONE | 4 | 0.0009 |
| 2 | BUSULFAN | 10 | 0.0006 |
| 3 | POLATUZUMAB VEDOTIN | 5 | 0.0005 |
| 4 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 5 | IMIQUIMOD | 1 | 0.0004 |
| 6 | FLUDARABINE PHOSPHATE | 12 | 0.0003 |
| 7 | DABRAFENIB | 6 | 0.0003 |
| 8 | BENDAMUSTINE HCL | 4 | 0.0003 |
| 9 | CHLORAMBUCIL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 1 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 13 | 0.0001 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 28 | 0.0001 |
| 5 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 9 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |